Sponsor Pipeline

Chong Kun Dang Pharmaceutical Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
12
Active Trials
6
Recruiting
2
Phase 3
7
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT06492655
To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers
overall status: Not Yet Recruiting → Unknown
2026-07-22 NCT07404735
A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of…
overall status: Not Yet Recruiting → Completed
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-06 NCT07748702 Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-339 in Healthy… Phase 1 Not Yet Recruiting
Active Trials by Phase
Phase 4
3
Phase 3
2
Phase 1/2
1
Phase 1
5
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06942156 Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors… Heart Transplant Not Yet Recruiting
NCT07365358 Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in… Diabete Type 2 Not Yet Recruiting
NCT05193565 Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in… Kidney Transplantation Active, Not Recruiting
Phase 3
NCT06643819 Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A Essential Hypertension Recruiting
NCT06916793 A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With… Androgenetic Alopecia Not Yet Recruiting
Phase 1/2
NCT07439094 A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer Advanced Solid Tumors Recruiting
Phase 1
NCT07258745 Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704… Psoriasis Recruiting
NCT07358156 A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of… Atopic Dermatitis Recruiting
NCT07215637 Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With… Advanced Solid Tumors Recruiting
NCT07532148 Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube… Ovarian Cancer Not Yet Recruiting
NCT07748702 Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-339 in Healthy… Hypertension Not Yet Recruiting
Not specified
NCT06838286 Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes Diabetes Mellitus, Type 2 Recruiting
Disease Areas
Get alerts when Chong Kun Dang Pharmaceutical's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free